181 results on '"van Putten, Maaike"'
Search Results
2. The therapeutic potential of soluble activin type IIB receptor treatment in a limb girdle muscular dystrophy type 2D mouse model
3. Antisense Oligonucleotide-Mediated Downregulation of IGFBPs Enhances IGF-1 Signaling
4. Networking to Optimize Dmd exon 53 Skipping in the Brain of mdx52 Mouse Model
5. Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
6. Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model
7. Voluntary exercise improves muscle function and does not exacerbate muscle and heart pathology in aged Duchenne muscular dystrophy mice
8. Diffusion‐tensor magnetic resonance imaging captures increased skeletal muscle fibre diameters in Becker muscular dystrophy
9. Efficient Downregulation of Alk4 in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
10. Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytes
11. On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics
12. Low dystrophin levels in heart can delay heart failure in mdx mice
13. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle
14. The predictive value of models of neuromuscular disorders to potentiate clinical translation
15. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle
16. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains
17. Spatial transcriptomics reveal markers of histopathological changes in Duchenne muscular dystrophy mouse models
18. The therapeutic potential of soluble activin type receptor IIB treatment in a limb girdle muscular dystrophy type 2D mouse model
19. HANDEDNESS AND ASYMMETRY IN SCALE-EATING CICHLIDS: ANTISYMMETRIES OF DIFFERENT STRENGTH
20. On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics.
21. A 3 months mild functional test regime does not affect disease parameters in young mdx mice
22. Efficient Downregulation of Alk4in Skeletal Muscle After Systemic Treatment with Conjugated siRNAs in a Mouse Model for Duchenne Muscular Dystrophy
23. Referee report. For: Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs [version 1; peer review: 1 approved with reservations]
24. Sexual Dimorphism in Transcriptional and Functional Glucocorticoid Effects on Mouse Skeletal Muscle.
25. Asymmetrical myofiber architecture along the murine tibialis anterior suggests distinct functional regions
26. 'Of Mice and Measures': A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic
27. A data-driven methodology reveals novel myofiber clusters in older human muscles
28. Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy
29. Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model
30. A data‐driven methodology reveals novel myofiber clusters in older human muscles
31. Mouse models for muscular dystrophies: an overview
32. Moving neuromuscular disorders research forward: from novel models to clinical studies
33. Asymmetrical myofiber architecture along the murine tibialis anterior suggests distinct functional regions
34. Discovering fiber type architecture over the entire muscle using data‐driven analysis.
35. The use of genetically humanized animal models for personalized medicine approaches
36. 240th ENMC workshop: The involvement of skeletal muscle stem cells in the pathology of muscular dystrophies 25–27 January 2019, Hoofddorp, The Netherlands
37. Cross-sectional study into age-related pathology of mouse models for limb girdle muscular dystrophy types 2D and 2F
38. A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy
39. Nonclinical Exon Skipping Studies with 2′-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn−/− Mice Inspired by Clinical Trial Results
40. High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns
41. Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
42. Update on Standard Operating Procedures in Preclinical Research for DMD and SMA Report of TREAT-NMD Alliance Workshop, Schiphol Airport, 26 April 2015, The Netherlands
43. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides
44. 227 th ENMC International Workshop
45. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
46. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
47. Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy.
48. High-throughput data-driven analysis of myofiber composition reveals muscle-specific disease and age-associated patterns.
49. Environmental 24-hr Cycles Are Essential for Health
50. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.